-
2 months ago | 
radcliffecardiology.com | James E. Udelson |Gregg W. Stone |Nisha Bansal |Antonio Ceriello
THT Conference 2025 - Positive safety and efficacy outcomes were found of the Reprieve decongestion management system (DMS; Reprieve Cardiovascular, Inc) for the treatment of acute decompensated heart failure (ADHF). Urinary sodium excretion was seen to be significantly higher in the Reprieve DMS arm than in the control arm, and there were fewer UTI infections in ADHF patients receiving the Reprieve DMS.
-
2 months ago | 
radcliffecardiology.com | Gregg W. Stone |Nisha Bansal |Antonio Ceriello |David C. Wheeler
Video Published: Views: 14 Likes: 0 Average (ratings) THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients.
-
Nov 1, 2024 | 
healio.com | Erik Swain |Richard Smith |Gregg W. Stone
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Orbital atherectomy was no better than balloon angioplasty for treatment of certain severely calcified coronary lesions. Atherectomy remains an option in lesions untreatable with balloons alone.
-
Apr 8, 2024 | 
healio.com | Erik Swain |Richard Smith |Wayne Batchelor |Gregg W. Stone
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: In patients with ACS who had angioplasty and stenting, ticagrelor monotherapy after 1 month reduced bleeding vs. ticagrelor plus aspirin for 12 months. The groups did not differ in ischemic events.
-
Apr 6, 2024 | 
healio.com | Scott Buzby |Erik Swain |Gregg W. Stone
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Inter-atrial shunt implant lowered HF hospitalization risk for patients with HFrEF vs. placebo. However, patients with HFpEF had more than threefold increased risk for all-cause mortality.
-
Mar 20, 2024 | 
nature.com | Azita H. Talasaz |Parham Sadeghipour |John Eikelboom |Deborah M. Siegal |Manuel Monreal |David Jimenez | +8 more
AbstractBalancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities.
-
Mar 20, 2024 | nature.com | Azita H. Talasaz |Parham Sadeghipour |John Eikelboom |Deborah M. Siegal |Manuel Monreal |David Jimenez | +8 more
AbstractBalancing the safety and efficacy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the potential for interference with the absorption of antithrombotic drugs and for an increased risk of bleeding. In this Review, we address considerations for enteral antithrombotic therapy in patients with cardiovascular disease and gastrointestinal comorbidities.
-
Feb 21, 2024 | 02454-6/abstract?rss=yes&sz=64)
thelancet.com | Gregg W. Stone |Evald H Christiansen |Yousif Ahmad |Lene N Andreasen
Summary Previous meta-analyses have shown reduced risks of composite adverse events with intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography guidance alone.
-
Jan 31, 2024 | 
onlinelibrary.wiley.com | Puja B. Parikh |Michael Mack |Gregg W. Stone |Stefan Anker
Corresponding Author Javed Butler Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA Baylor Scott and White Research Institute, Dallas, TX, USA Corresponding authors. Javed Butler, MD, Baylor Scott and White Research Institute, 3434 Oak Street Ste 501, Dallas, TX 75204, USA. Tel: +1 601 984-5600, Fax: +1 601 984-5608, Email: [email protected] Puja B.
-
Nov 11, 2023 | 
jacc.org | Björn Redfors |Gregg W. Stone |John Alexander |Eric Bates
AbstractBackgroundIn the ISCHEMIA trial, the risk of ischemic events was similar in patients with stable coronary artery disease treated with an invasive (INV) strategy of angiography and percutaneous (PCI) or surgical (CABG) coronary revascularization and a conservative (CON) strategy of initial medical therapy. ObjectiveTo analyze separately the outcomes of INV patients treated with PCI or CABG.
